Stock report · NYSE
Becton, Dickinson and Company (BDX)
…

BDX stock chart
Key statistics
About Becton, Dickinson and Company
Becton, Dickinson and Company, founded in 1897 and based in Franklin Lakes, New Jersey, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. These products serve healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public worldwide. The company's operations are organized into three main segments: BD Medical, BD Life Sciences, and BD Interventional.
The BD Medical segment offers a wide range of products, including peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, and needle-free IV connectors. It also provides closed-system drug transfer devices, hazardous drug detection systems, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems. Additionally, BD Medical delivers IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, medication inventory optimization and tracking systems, syringes, pen needles, and other diabetes care products, as well as prefillable drug delivery systems.
The BD Life Sciences segment focuses on specimen and blood colection products, automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility testing, and liquid-based cytology systems. This segment also offers rapid diagnostic assays, microbiology laboratory automation products, plated media products, fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis. Furthermore, it provides clinical oncology, immunological, and transplantation diagnostic and monitoring reagents and analyzers.
The BD Interventional segment provides products for hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical applications. It also offers surgical infection prevention products, surgical and laparoscopic instrumentation, peripheral intervention products, and urology and critical care products. With a long history of innovation and a comprehensive portfolio of products, Becton, Dickinson and Company continues to be a leader in the medical technology industry, enhancing patient care and advancing the field of medical science.
Becton, Dickinson and financials at a glance
More on Becton, Dickinson and: BDX stock quote, chart and news on QuoteLinks
Quotes may be delayed. Market data is provided for information only and is not investment advice; see our disclaimer.